Approvals/TGA/ADAKVEO crizanlizumab 10 mg/mL concentrate for solution for infusion vial

Approved

STANDARD

ADAKVEO crizanlizumab 10 mg/mL concentrate for solution for infusion vial

Approval Id: 3e44e3bd2dfe9084
Product Name: ADAKVEO crizanlizumab 10 mg/mL concentrate for solution for infusion vial
Artg Id: 327317
Artg Name: ADAKVEO crizanlizumab 10 mg/mL concentrate for solution for infusion vial
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2021-04-08
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

3e44e3bd2dfe9084

Type

Standard